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Definitions
Pulmonary hypertension (PH) is defined as elevated pulmonary artery pressure (PAP) secondary to various pathophysiologies causing cor pulmonale and eventually right sided heart failure. The WHO classification of PH is based on similarities in pathophysiologic mechanisms (see table below). Specific hemodynamic criteria include systolic PAP >30 mmHg, diastolic PAP >20 mmHg, mean PAP >25 mmHg, pulmonary capillary wedge pressure <15 mmHg. Cor pulmonale refers to right ventricular hypertrophy secondary to PH.
Pulmonary arterial hypertension (PAH)
is
E tiology and pathophysiology
In PAH, the underlying vascular injury is thought to be a final common response to various inciting factors coupled with genetic susceptibility. Eliciting factors may be mechanical (overperfusion), drugs (experimentally inducible with appetite suppressants), toxins, infections, and genetically determined susceptibility to such 
A dvanced or confirmatory testing
Contrast ultrasound (microbubbles) of the heart and descending aorta to rule out cardiovascular right-to-left shunt. Shunt is also possible due to pulmonary arteriovenous fistula secondary to pulmonary hypertension; in this case, bubbles will take at least 3 cardiac cycles from their appearance in the right atrium till their appearance in the left atrium. Specific treatment of underlying mechanism or disease in secondary PH (Heart Failure, Pulmonary Thromboembolism, Dirofilariosis, Angiostrongylosis)
